Pinosol drops naz. fl. 10 ml # 1

Release form, composition and packaging

?

Nasal drops in the form of a clear liquid from blue to green-blue in color, with a menthol-eucalyptus smell.

10 g (1 fl.)

Scots pine oil 375.2 mg

eucalyptus oil 50 mg

thymol 3.2 mg

α-tocopherol acetate 170 mg

peppermint oil 100 mg

guayazulene 2 mg

butylhydroxyanisole - 1.2 mg, esters of macrogol and glycerides of apricot oil (labrafil M-1944-CS) - 1 g, vegetable oil - 8.2985 g. 10 ml - brown glass bottles with a rubber pipette with a lid (1) - cardboard packs.

pharmachologic effect

Herbal decongestant.

It has anti-inflammatory and antiseptic properties.

Pharmacokinetics

Data on the pharmacokinetics of Pinosol® are not available.

Indications for use

- acute rhinitis

- chronic atrophic rhinitis

- acute and chronic inflammatory diseases of the mucous membranes of the nose and nasopharynx, accompanied by dryness of the mucous membranes of the nose

- conditions after surgery in the nasal cavity - as prescribed by a doctor (in a hospital and outpatient setting).

Contraindications for use

- allergic rhinitis

- children under 2 years old

- hypersensitivity to drug components.

Dosage regimen

For adults, on the 1st day, the drug is instilled in 1-2 drops into each nasal passage with an interval of 1-2 hours. In the following days - 1-2 drops in each nasal passage 3-4 times / day.

Children are instilled 1-2 drops 3-4 times / day or use a cotton swab.

It is possible to use the drug in the form of inhalation, which should be carried out using an inhaler.

For this, 2 ml (50 drops) is instilled into the inhaler

frequency of application - 2-3 times / day.

The duration of treatment is 5-7 days.

Overdose

Until now, there have been no cases of overdose of Pinosol®.

Side effect

Local reactions: itching, burning sensation, hyperemia and swelling of the nasal mucosa.

Drug interactions

The drug interaction of the drug Pinosol® is not described.

Application during pregnancy and lactation

It is possible to use the drug Pinosol® during pregnancy and lactation (breastfeeding) according to indications.

Special instructions In the event of adverse events or other unusual reactions not described in the instructions, the patient should consult a doctor.

Name ENG

PINOSOL

Clinical and pharmacological group

Antimicrobial and anti-inflammatory drug for topical use in ENT practice

ATX code

Decongestants and other topical preparations

Dosage

etc.

x 10ml

Structure

Active ingredients: Scots pine oil

eucalyptus oil

alpha-tocopherol acetate

thymol

peppermint oil

guaiazulene

Excipients: butylhydroxyanisole

macrogol and apricot oil glycerides esters (labrafil M-1944-CS)

vegetable oil

Indications

acute rhinitis

chronic atrophic rhinitis

acute and chronic inflammatory diseases of the mucous membranes of the nose and nasopharynx, accompanied by dryness of the mucous membranes of the nose

conditions after surgery in the nasal cavity - as prescribed by a doctor (in a hospital and outpatient setting).

Contraindications

allergic rhinitis

children under 2 years of age

hypersensitivity to drug components.

INN / Active ingredient

Alpha-Tocopherol Acetate, Guayazulene, Thymol, Eucalyptus Oil, Peppermint Oil, Common Pine Oil

Storage conditions and periods

At a temperature of 15-25 degrees. (In the original packaging).

Expiration date: 3 years

Specifications

Category

Runny nose

Scope of the drug

Ear, Throat, Nose

Release form

Drops

Manufacturer country

Slovakia

Package quantity, pcs

one

Scope of application

Virology

Minimum age from

2 years old

Way of introduction

Through the respiratory tract

Vacation conditions

Without recipe

Brand name

Zentiva

The amount of the dosage form in the primary package

10 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Herbal decongestant

Dosage form

Nasal drops

Expiration date in days

1095

The target audience

Children

Package weight, g

45

Mode of application

:

Locally.

< br> For adults, the drug is instilled on the first day, 1-2 drops in each nasal passage at intervals of 1-2 hours, on subsequent days - 1-2 drops in each nasal passage 3-4 times a day

children - 1-2 drops 3-4 times a day or use a cotton swab.

< br> It is possible to use the drug for inhalation, for which 2 ml (50 drops) is instilled into the inhaler.

Inhalation is recommended 2-3 times a day.

< br> Duration of treatment - 5-7 days.

Anatomical and therapeutic characteristics

:

R01AX30 Topical nasal preparations in combination

Dosage (volume) of the substance in the preparation

:

Eucalyptus oil 50 mg, Scots pine oil 372.5 mg, peppermint oil 100 mg, thymol 3.2 mg, guaiazulene 2 mg, alpha-tocopherol acetate 170 mg

Information on technical characteristics, delivery set, country of manufacture